MITOCHONDRIA AND MICROBIOME LEADERSHIP
At the opposite of conventional process, we invest in free-spirited scientists who challenge existing solutions and pioneer new ways, we offer them resources and access to technologies that allow to translate prototypes into scalable solutions. our ultimate mission is to invent better, faster, sustainable solutions that can improve humans’ health at great value.
Ninapharm purpose is to study the impact of extreme conditions on the microbiome of humans and plants and develop technologies to support better health resilience and longevity by learning from nature’s force to evolve and adapt. In extreme conditions, the microbiome adapts and evolves into a stronger version faster than normal, leading to drastic changes in the epigenome and gene expression on human health. This discovery inspired Ninapharm to develop the Darwin platform that targets modulating genome by impacting the microbiome. Darwin platform is a platform model that takes a strong microbiome, lets them evolve under extreme conditions, and re-introduce them into the original site to speed up evolution. Through bioprospection of strains in extreme environments and using the artificial intelligence program GLOTRAI to develop epigenetic technologies, Ninapharm develops microbiome-based formulations that impact the human microbiome and target mitochondria to improve human longevity and resilience.
